Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The Chinese-German Journal of Clinical Oncology
Metadata
Title
Prospective comparative study of cool-tip radiofrequency ablation and surgical resection for hepatocellular carcinoma
Authors
Wentao Kong
Weiwei Zhang
Yudong Qiu
Tie Zhou
Han Bin
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
The Chinese-German Journal of Clinical Oncology / Issue 7/2011
Print ISSN: 1610-1979
Electronic ISSN: 1613-9089
DOI
https://doi.org/10.1007/s10330-011-0817-4

Other articles of this Issue 7/2011

The Chinese-German Journal of Clinical Oncology 7/2011 Go to the issue

OriginalPaper

COX-2 silencing inhibits cell proliferation in A549 cell

OriginalPaper

Clinical study on gefitinib combined with γ-ray stereotactic radiotherapy for senile patients with adenocarcinoma of lung as the first-line regimen

OriginalPaper

Primary synovial sarcoma of pericardium: A case report

OriginalPaper

Predictive biomarker and clinicopathological characteristics analysis for recurrence of early gastric cancer

OriginalPaper

The side effects of docetaxel with cyclophosphamide as postoperative adjuvant chemotherapy for elderly breast cancer patients

OriginalPaper

Immunohistochemical study of nuclear factor-κB activity in colorectal cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits